Ultragenyx Pharmaceutical Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€34.60
Target price
04.08.24
€86.28
Performance (%)
30.06%
End price
05.08.24
€45.00
Summary
This prediction ended on 05.08.24 with a price of €45.00. The BUY prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc. saw massive gains of 30.06%. Morgan_Stanley has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.643% | -7.643% | -30.952% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Morgan_Stanley for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $95.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€31.20
09.05.25
09.05.25
€57.96
09.05.26
09.05.26
-7.69%
07:32
07:32
Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€24.00
14.07.25
14.07.25
€47.06
14.07.26
14.07.26
20.00%
07:32
07:32
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.60
03.11.23
03.11.23
€78.49
03.11.24
03.11.24
30.05%
04.11.24
04.11.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
10.10.23
10.10.23
€84.74
10.10.24
10.10.24
43.02%
11.10.24
11.10.24